Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1986 Jul;88(3):497–499. doi: 10.1111/j.1476-5381.1986.tb10228.x

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism.

W D Miner, G J Sanger
PMCID: PMC1916988  PMID: 3742146

Abstract

MDL 72222, the selective 5-hydroxytryptamine (5-HT) M-receptor antagonist, prevented or reduced cisplatin-induced emesis in ferrets. It is suggested that cisplatin-induced, and possibly other cytotoxic drug-induced vomiting may involve a 5-HT M-receptor mechanism.

Full text

PDF
497

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Florczyk A. P., Schurig J. E., Bradner W. T. Cisplatin-induced emesis in the Ferret: a new animal model. Cancer Treat Rep. 1982 Jan;66(1):187–189. [PubMed] [Google Scholar]
  2. Fozard J. R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):36–44. doi: 10.1007/BF00518776. [DOI] [PubMed] [Google Scholar]
  3. Fozard J. R. Neuronal 5-HT receptors in the periphery. Neuropharmacology. 1984 Dec;23(12B):1473–1486. doi: 10.1016/0028-3908(84)90091-1. [DOI] [PubMed] [Google Scholar]
  4. Gralla R. J., Itri L. M., Pisko S. E., Squillante A. E., Kelsen D. P., Braun D. W., Jr, Bordin L. A., Braun T. J., Young C. W. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981 Oct 15;305(16):905–909. doi: 10.1056/NEJM198110153051601. [DOI] [PubMed] [Google Scholar]
  5. Harrington R. A., Hamilton C. W., Brogden R. N., Linkewich J. A., Romankiewicz J. A., Heel R. C. Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs. 1983 May;25(5):451–494. doi: 10.2165/00003495-198325050-00002. [DOI] [PubMed] [Google Scholar]
  6. Harris A. L. Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet. 1982 Mar 27;1(8274):714–716. doi: 10.1016/s0140-6736(82)92625-3. [DOI] [PubMed] [Google Scholar]
  7. Leslie R. A., Gwyn D. G. Neuronal connections of the area postrema. Fed Proc. 1984 Dec;43(15):2941–2943. [PubMed] [Google Scholar]
  8. McCarthy L. E., Borison H. L. Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats. Cancer Treat Rep. 1984 Feb;68(2):401–404. [PubMed] [Google Scholar]
  9. Pickel V. M., Armstrong D. M. Ultrastructural localization of monoamines and peptides in rat area postrema. Fed Proc. 1984 Dec;43(15):2949–2951. [PubMed] [Google Scholar]
  10. Tonato M., Roila F., del Favero A., Tognoni G., Franzosi M. G., Pampallona S. A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin. Eur J Cancer Clin Oncol. 1985 Jul;21(7):807–810. doi: 10.1016/0277-5379(85)90219-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES